RTI-5152-12
Chemical compound
Overview[edit]
RTI-5152-12 is a chemical compound that belongs to the class of phenyltropanes, which are known for their stimulant properties. This compound is a derivative of the tropane alkaloid structure and is primarily studied for its potential effects on the central nervous system.
Chemical Structure[edit]
RTI-5152-12 is characterized by its complex chemical structure, which includes a tropane ring system. The compound is a derivative of the phenyltropane class, which is known for its structural similarity to cocaine. The presence of specific functional groups in RTI-5152-12 contributes to its unique pharmacological profile.
Pharmacology[edit]
RTI-5152-12 acts primarily as a dopamine reuptake inhibitor, which means it blocks the reabsorption of dopamine into neurons, leading to increased levels of dopamine in the synaptic cleft. This action is similar to that of other stimulant drugs, which can enhance mood, increase alertness, and improve concentration.
The compound's effects on the dopaminergic system make it a subject of interest in the study of neurotransmitter regulation and potential therapeutic applications for disorders such as attention deficit hyperactivity disorder (ADHD) and narcolepsy.
Potential Applications[edit]
While RTI-5152-12 is primarily a research chemical, its properties as a dopamine reuptake inhibitor suggest potential applications in the treatment of neurological and psychiatric disorders. However, further research is necessary to fully understand its efficacy and safety profile.
Safety and Legal Status[edit]
As a research chemical, RTI-5152-12 is not approved for medical use in humans. Its legal status may vary by country, and it is typically regulated under laws pertaining to controlled substances. Researchers must adhere to strict guidelines when handling and studying this compound.
Related Compounds[edit]
RTI-5152-12 is part of a broader class of phenyltropanes, which includes other compounds such as RTI-55 and RTI-113. These compounds share similar mechanisms of action but differ in their potency and selectivity for various neurotransmitter systems.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
